Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (44)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Prusa, A.-R.
Right arrow Articles by Hengstschläger, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prusa, A.-R.
Right arrow Articles by Hengstschläger, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 18, No. 7, 1489-1493, July 2003
© 2003 European Society of Human Reproduction and Embryology

Oct-4-expressing cells in human amniotic fluid: a new source for stem cell research?

Andrea-Romana Prusa, Erika Marton, Margit Rosner, Gerhard Bernaschek and Markus Hengstschläger1

Obstetrics and Gynecology, University of Vienna, Prenatal Diagnosis and Therapy, Währinger Gürtel 18–20, 1090 Vienna, Austria

1 To whom correspondence should be addressed. e-mail: markus.hengstschlaeger{at}akh-wien.ac.at

BACKGROUND: It is the hope of investigators and patients alike that in future the isolation of pluripotent human stem cells will allow the establishment of therapeutic concepts for a wide variety of diseases. A major aim in this respect is the identification of new sources for pluripotent stem cells. Oct-4 is a marker for pluripotent human stem cells so far known to be expressed in embryonal carcinoma cells, embryonic stem cells and embryonic germ cells. METHODS: Cells from human amniotic fluid samples were analysed for mRNA expression of Oct-4, stem cell factor, vimentin and alkaline phosphatase via RT–PCR. Oct-4 protein expression was investigated by Western blot analysis and immunocytochemistry. Oct-4-positive cells were also analysed for the expression of cyclin A protein via double immunostaining. RESULTS: Performing RT–PCR, Western blot and immunocytochemical analyses revealed that in human amniotic fluid in the background of Oct-4-negative cells a distinct population of cells can be found, which express Oct-4 in the nucleus. Oct-4-positive amniotic fluid cell samples also express stem cell factor, vimentin and alkaline phosphatase mRNA. The Oct-4-positive amniotic fluid cells are actively dividing, proven by the detection of cyclin A expression. CONCLUSIONS: The results presented here suggest that human amniotic fluid may represent a new source for the isolation of human Oct-4-positive stem cells without raising the ethical concerns associated with human embryonic research.

Key words: human amniotic fluid/Oct-4/pluripotency/stem cells


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum Mol GenetHome page
C. Li, J. Zhou, G. Shi, Y. Ma, Y. Yang, J. Gu, H. Yu, S. Jin, Z. Wei, F. Chen, et al.
Pluripotency can be rapidly and efficiently induced in human amniotic fluid-derived cells
Hum. Mol. Genet., November 15, 2009; 18(22): 4340 - 4349.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Ditadi, P. de Coppi, O. Picone, L. Gautreau, R. Smati, E. Six, D. Bonhomme, S. Ezine, R. Frydman, M. Cavazzana-Calvo, et al.
Human and murine amniotic fluid c-Kit+Lin- cells display hematopoietic activity
Blood, April 23, 2009; 113(17): 3953 - 3960.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
J. M. W. Slack
Origin of Stem Cells in Organogenesis
Science, December 5, 2008; 322(5907): 1498 - 1501.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
J. H. Moon, J. R. Lee, B. C. Jee, C. S. Suh, S. H. Kim, H. J. Lim, and H. K. Kim
Successful vitrification of human amnion-derived mesenchymal stem cells
Hum. Reprod., August 1, 2008; 23(8): 1760 - 1770.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
M.-S. Tsai, S.-M. Hwang, Y.-L. Tsai, F.-C. Cheng, J.-L. Lee, and Y.-J. Chang
Clonal Amniotic Fluid-Derived Stem Cells Express Characteristics of Both Mesenchymal and Neural Stem Cells
Biol Reprod, March 1, 2006; 74(3): 545 - 551.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
S. Sartore, M. Lenzi, A. Angelini, A. Chiavegato, L. Gasparotto, P. D. Coppi, R. Bianco, and G. Gerosa
Amniotic mesenchymal cells autotransplanted in a porcine model of cardiac ischemia do not differentiate to cardiogenic phenotypes
Eur. J. Cardiothorac. Surg., November 1, 2005; 28(5): 677 - 684.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
G. Cauffman, H. Van de Velde, I. Liebaers, and A. Van Steirteghem
Oct-4 mRNA and protein expression during human preimplantation development
Mol. Hum. Reprod., March 1, 2005; 11(3): 173 - 181.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M.-H. Tai, C.-C. Chang, L.K. Olson, and J. E. Trosko
Oct4 expression in adult human stem cells: evidence in support of the stem cell theory of carcinogenesis
Carcinogenesis, February 1, 2005; 26(2): 495 - 502.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
M.-S. Tsai, J.-L. Lee, Y.-J. Chang, and S.-M. Hwang
Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol
Hum. Reprod., June 1, 2004; 19(6): 1450 - 1456.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.